{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:07:40Z","timestamp":1789049260962,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jaci.2021.09.034","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T09:23:32Z","timestamp":1634635412000},"page":"51-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["BCG vaccine\u2019s off-target effects on allergic, inflammatory, and autoimmune diseases: Worth another shot?"],"prefix":"10.1016","volume":"149","author":[{"given":"Asimenia","family":"Angelidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure F.","family":"Pittet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Faustman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.09.034_bib1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/all.13314","article-title":"Neonatal BCG vaccination and atopic dermatitis before 13 months of age: a randomized clinical trial","volume":"73","author":"Th\u00f8stesen","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.09.034_bib2","doi-asserted-by":"crossref","unstructured":"Pittet L, Messina N, Freyne B, Gardiner K, Abruzzo V, Francis K, et al. Prevention of infant eczema by neonatal bacille Calmette-Gu\u00e9rin vaccination: the MIS BAIR randomized controlled trial [e-pub ahead of print]. Allergy https:\/\/doi.org\/10.1111\/all.15022.","DOI":"10.1111\/all.15022"},{"key":"10.1016\/j.jaci.2021.09.034_bib3","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/all.14771","article-title":"Childhood vaccination and allergy: a systematic review and meta-analysis","volume":"76","author":"Navaratna","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.09.034_bib4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fmicb.2020.00332","article-title":"BCG as a case study for precision vaccine development: lessons from vaccine heterogeneity, trained immunity, and immune ontogeny","volume":"11","author":"Angelidou","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jaci.2021.09.034_bib5","doi-asserted-by":"crossref","first-page":"13644","DOI":"10.1073\/pnas.0803429105","article-title":"Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism","volume":"105","author":"Ban","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jaci.2021.09.034_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-018-0062-8","article-title":"Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations","volume":"3","author":"K\u00fchtreiber","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jaci.2021.09.034_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8954125","article-title":"Therapeutic effects of BCG vaccination on type 1 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"2020","author":"Chang","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jaci.2021.09.034_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/01.wnl.0000438216.93319.ab","article-title":"Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS","volume":"82","author":"Ristori","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jaci.2021.09.034_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00415-003-0967-6","article-title":"The effect of Bacille Calmette-Gu\u00e9rin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MS","volume":"250","author":"Paolillo","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.jaci.2021.09.034_bib10","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jaci.2016.12.985","article-title":"Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses","volume":"140","author":"Dowling","year":"2017","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921015530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921015530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:37:11Z","timestamp":1758793031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921015530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0091674921015530"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.09.034","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG vaccine\u2019s off-target effects on allergic, inflammatory, and autoimmune diseases: Worth another shot?","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}